v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jun. 27, 2026
Jun. 28, 2025
Cash flows from operating activities:    
Net income $ 209,736 $ 107,015
Adjustments to reconcile net income to cash used in operating activities:    
Depreciation and amortization 98,965 97,981
Stock-based compensation 24,211 9,089
Non-cash charges for interest and bond discount amortization 9,535 9,352
Amortization of lease right-of-use asset 65,194 62,065
Deferred income taxes (29,057) (26,854)
(Gain) loss on foreign exchange (15,884) 45,493
Loss on write-down of assets held-for-sale 0 32,757
Other 9,673 (4,896)
Changes in operating assets and liabilities, net of effects of acquisitions:    
Trade accounts receivable (277,523) 463,238
Inventory (1,108,621) (623,888)
Other assets (206,353) (187,387)
Accounts payable 50,605 (132,604)
Change in book overdrafts (135,055) (184,060)
Operating lease liabilities (61,635) (87,639)
Accrued expenses and other (144,885) (78,052)
Cash used in operating activities (1,511,094) (498,390)
Cash flows from investing activities:    
Capital expenditures (69,223) (64,961)
Proceeds from deferred purchase price of factored receivables 90,629 141,445
Issuance of notes receivable (12,375) (12,501)
Proceeds from notes receivable 15,134 20,510
Proceeds from sale of equity investments 0 20,805
Other 10,751 11,420
Cash provided by investing activities 34,916 116,718
Cash flows from financing activities:    
Dividends paid to stockholders (38,352) (40,828)
Change in unremitted cash collections from servicing factored receivables (2,218) (3,587)
Repurchase of Common Stock (105,000) 0
Repayment of Term Loans (200,000) (125,000)
Gross proceeds from other debt 32,671 29,820
Gross repayments of other debt (41,210) (32,574)
Net proceeds from revolving and other credit facilities 812,823 452,161
Other (11,155) (7,019)
Cash provided by financing activities 447,559 272,973
Effect of exchange rate changes on cash, cash equivalents and restricted cash (2,394) 46,966
Decrease in cash, cash equivalents and restricted cash (1,031,013) (61,733)
Cash, cash equivalents and restricted cash at beginning of period 1,864,724 918,401
Cash, cash equivalents and restricted cash at end of period 833,711 856,668
Supplemental disclosure of non-cash investing information:    
Amounts obtained as a beneficial interest in exchange for transferring trade receivables in factoring arrangements $ 82,914 $ 128,961